Complex Health Challenges I - Cardiac Disorders Questions And Correct Verified Answers

COMPLEX HEALTH CHALLENGES I -
CARDIAC DISORDERS QUESTIONS AND
CORRECT VERIFIED ANSWERS
PlaceA2inA2sequenceA2ofA2theA2developmentalA2stagesA2ofA2atheroscleroticA2lesions.
A.A2FattyA2streak
B.A2ComplicatedA2lesion
C.A2ChronicA2endothelialA2injury
D.A2FibrousA2plaqueA2-A2Ans--C,A2A,A2D,A2B

WhichA2termA2isA2consideredA2synonymousA2withA2coronaryA2arteryA2diseaseA2(CAD)?
A2SelectA2allA2thatA2apply.A2One,A2some,A2orA2allA2responsesA2mayA2beA2correct.
A.A2ArterioscleroticA2heartA2diseaseA2(ASHD)
B.A2CongenitalA2heartA2disease
C.A2Wolff-Parkinson-WhiteA2(WPW)A2syndrome
D.A2CardiovascularA2heartA2diseaseA2(CVHD)
E.A2IschemicA2heartA2disease
F.A2CoronaryA2heartA2diseaseA2-A2Ans--A,A2D,A2E,A2F

WhichA2statementA2aboutA2collateralA2circulationA2isA2accurate?
A.A2NewA2arterialA2anastomosesA2formA2onlyA2whenA2necessaryA2toA2increaseA2bloodA2flo
w.
B.A2Rapid-
onsetA2heartA2diseaseA2causesA2immediateA2formationA2ofA2collateralA2circulationA2providi
ngA2sufficientA2bloodA2supply.
C.A2GeneticsA2playA2aA2roleA2inA2aA2person'sA2abilityA2toA2developA2collateralA2circulation.
D.A2CollateralA2circulationA2developsA2onlyA2whenA2atheroscleroticA2changesA2decreaseA2
arterialA2bloodA2flowA2toA2theA2myocardium.A2-A2Ans--C
TheA2inheritedA2predispositionA2toA2developA2newA2bloodA2vesselsA2(angiogenesis)A2prom
otesA2theA2presenceA2ofA2collateralA2circulation.

WhichA2factorA2isA2aA2majorA2modifiableA2riskA2forA2coronaryA2arteryA2diseaseA2(CAD)?
A.A2Depression
B.A2SubstanceA2use
C.A2DiabetesA2mellitus
D.A2TobaccoA2useA2-A2Ans--D

WhichA2statementA2differentiatesA2coronaryA2arteryA2diseaseA2(CAD)A2riskA2betweenA2mal
esA2andA2females?
A.A2WomenA2areA2atA2moreA2riskA2thanA2menA2untilA2ageA265.
B.A2At-
riskA2waistA2circumferenceA2measurementsA2doA2notA2differA2forA2menA2andA2women.
C.A2ReproductiveA2influencesA2affectA2CADA2riskA2forA2women.
D.A2MenA2haveA2moreA2stressfulA2jobs,A2thereforeA2areA2atA2higherA2risk.A2-A2Ans--C

,WomenA2experienceA2differentA2riskA2relatedA2toA2theA2femaleA2reproductiveA2system,A2in
cludingA2earlyA2ageA2ofA2menarche,A2contraceptiveA2use,A2pregnancy,A2andA2prematureA2
menopause.

WhichA2substanceA2isA2derivedA2fromA2triglycerides?
A.A2Phospholipids
B.A2FattyA2acids
C.A2Chylomicrons
D.A2LowA2densityA2lipoproteinsA2-A2Ans--B

WhichA2individualA2wouldA2theA2nurseA2identifyA2asA2havingA2theA2highestA2riskA2forA2coro
naryA2arteryA2diseaseA2(CAD)?
A.A2AA245-year-oldA2depressedA2maleA2withA2aA2high-stressA2job
B.A2AA260-year-oldA2maleA2withA2below-normalA2homocysteineA2levels
C.A2AA254-year-oldA2femaleA2vegetarianA2withA2elevatedA2high-
densityA2lipoproteinA2(HDL)A2levels
D.A2AA262-year-
oldA2femaleA2whoA2hasA2aA2sedentaryA2lifestyleA2andA2bodyA2massA2indexA2(BMI)A2ofA223A
2kg/m2A2-A2Ans--A
StudiesA2demonstrateA2thatA2depressionA2andA2stressfulA2statesA2canA2contributeA2toA2the
A2developmentA2ofA2CAD.A2ThisA2patientA2hasA2twoA2riskA2factors.


WhichA2statementA2aboutA2diabetesA2mellitusA2doesA2theA2nurseA2takeA2intoA2consideratio
nA2whenA2planningA2coronaryA2arteryA2diseaseA2(CAD)A2riskA2reductionA2educationA2forA2I
ndigenousA2people?
A.A2BecauseA2CADA2isA2notA2commonA2inA2theA2IndigenousA2population,A2riskA2reductionA
2educationA2isA2notA2necessary.
B.A2IndigenousA2peopleA2rarelyA2developA2diabetesA2mellitusA2dueA2toA2theirA2lowA2relianc
eA2onA2processedA2foods.
C.A2IndigenousA2peopleA2areA2lessA2likelyA2toA2developA2complicationsA2fromA2theirA2diabe
tesA2suchA2asA2CAD.
D.A2TheA2incidenceA2ofA2diabetesA2inA2IndigenousA2peopleA2isA2veryA2high.A2-A2Ans--D
DiabetesA2isA2consideredA2endemicA2inA2theA2IndigenousA2population,A2andA2theyA2areA2at
A2veryA2highA2riskA2ofA2developingA2diabetesA2associatedA2complications;A2therefore,A2CA
DA2riskA2reductionA2shouldA2beA2emphasizedA2whenA2providingA2theirA2healthA2care.

WhichA2statementA2describesA2theA2relationshipA2betweenA2coronaryA2arteryA2diseaseA2(
CAD)A2riskA2andA2substanceA2use?
A.A2PatientsA2underA2theA2influenceA2ofA2illicitA2drugsA2admittedA2toA2theA2emergencyA2dep
artmentA2predominatelyA2areA2experiencingA2aA2myocardialA2infarctionA2(MI).
B.A2TheA2majorA2riskA2associatedA2withA2illicitA2drugA2useA2isA2theA2increasedA2riskA2ofA2cor
onaryA2arteryA2spasm.
C.A2IndigenousA2peopleA2areA2atA2lessA2riskA2forA2CADA2associatedA2withA2substanceA2us
eA2thanA2non-indigenousA2people.
D.A2CannabisA2hasA2beenA2legalizedA2inA2CanadaA2asA2thereA2areA2noA2knownA2CADA2ris
kA2factors.A2-A2Ans--B

, TheA2useA2ofA2illicitA2drugs,A2suchA2asA2cocaineA2andA2methamphetamine,A2canA2produce
A2coronaryA2arteryA2spasmA2resultingA2inA2myocardialA2ischemiaA2andA2chestA2pain.


ForA2whichA2antilipidemicA2medicationA2wouldA2theA2nurseA2questionA2anA2orderA2inA2aA2p
atientA2withA2cirrhosisA2ofA2theA2liver?
A.A2Niacin
B.A2Ezetimibe
C.A2Cholestyramine
D.A2ColestipolA2-A2Ans--B
EzetimibeA2actsA2inA2theA2smallA2intestineA2toA2inhibitA2uptakeA2ofA2cholesterol.A2AdverseA
2effectsA2areA2infrequent,A2butA2includeA2mildA2GIA2disturbanceA2(e.g.,A2diarrhea)A2fatigue,
A2headache,A2andA2cough.A2ItsA2useA2wouldA2beA2avoidedA2inA2patientsA2withA2moderateA2
toA2severeA2liverA2diseaseA2andA2pregnantA2orA2breast-feedingA2persons.

MatchA2theA2typeA2ofA2fatA2toA2itsA2associatedA2food.
A.A2EggA2yolk
B.A2Avocado
C.A2Flaxseed
D.A2Butter

1.A2Monounsaturated
2.A2SaturatedA2
3.A2Unsaturated
4.A2Saturated
5.A2PolyunsaturatedA2-A2Ans--AA2-A22
BA2-A21
CA2-A25
DA2-A24

WhichA2behaviourA2wouldA2beA2consistentA2withA2coronaryA2arteryA2diseaseA2(CAD)A2riskA
2reduction?
A.A2ExerciseA2regularlyA2toA2meetA2theA2recommendedA2targetA2ofA2250A2minutes/week.
B.A2LimitA2saltA2intakeA2toA22300A2mg/day.
C.A2ModifyA2lifestyleA2choicesA2toA2obtain/maintainA2aA2BMIA2betweenA224.9-38.5.
D.A2LimitA2caloricA2intakeA2toA21A2200A2calories/day.A2-A2Ans--B

WhichA2changeA2occursA2inA2coronaryA2arteryA2diseaseA2(CAD)?
A2SelectA2allA2thatA2apply.A2One,A2some,A2orA2allA2responsesA2mayA2beA2correct.
A.A2DiffuseA2involvementA2ofA2plaqueA2formationA2inA2coronaryA2veins
B.A2AbnormalA2levelsA2ofA2cholesterol,A2especiallyA2low-densityA2lipoproteins
C.A2AccumulationA2ofA2lipidA2plaquesA2orA2calcificationA2withinA2theA2coronaryA2arteries
D.A2DevelopmentA2ofA2anginaA2dueA2toA2aA2decreasedA2bloodA2supplyA2toA2theA2heartA2mu
scle
E.A2ChronicA2vasoconstrictionA2ofA2coronaryA2arteriesA2leadingA2toA2permanentA2vasospa
smA2-A2Ans--B,A2C,A2D